Three-Factor Model of Insomnia
| Factor | Description | Examples |
| Predisposing | Genetic/early life vulnerabilities | Light sleeper, high psychological reactivity |
| Precipitating | Triggering event | Job loss, divorce, accident, illness |
| Perpetuating | Behaviors that maintain the problem | Napping, phone in bed, sleeping pills, irregular schedule |
Key Insight
CBT-I focuses almost entirely on perpetuating factors, regardless of cause.
Core CBT-I Components
1. Stimulus Control
Principle: The bed becomes associated only with sleep (and sex).
| Rule | Rationale |
| Bed is only for sleep and sex | Creates associative conditioning |
| No reading in bed | Prevents bed-wakefulness association |
| No screens in bed | Removes stimulating activities |
| No lying awake in bed | Get up if not sleeping |
| No camping in bed “in case” you sleep | Breaks pattern of bed = wakefulness |
2. Time in Bed Restriction
Principle: Match time in bed to actual sleep capacity.
| Step | Action |
| 1 | Complete 7-day sleep diary |
| 2 | Calculate average sleep time |
| 3 | Add 30 minutes to get “time in bed” allowance |
| 4 | Set consistent wake time based on diary patterns |
| 5 | Calculate bedtime working backward from wake time |
Example: Diary shows 6 hours average sleep → Add 30 minutes = 6.5 hours allowed in bed → Wake time chosen: 6:00 AM → Bedtime: 11:30 PM. Minimum: No therapist restricts below 5.5 hours in bed.
Sleep Efficiency and Expansion
| Metric | Definition |
| Sleep efficiency | (Time asleep ÷ Time in bed) × 100 |
| Target | 85% or higher |
| Expansion rate | 15 minutes per week once target achieved |
Progression: After 4 weeks at 85% efficiency, patients gain an extra hour of sleep per night.
3. Cognitive Restructuring
Principle: Challenge dysfunctional thoughts about sleep.
| Step | Action |
| 1 | Write down the thought |
| 2 | Rate emotional distress (0–90%) |
| 3 | List evidence FOR the thought |
| 4 | List evidence AGAINST the thought |
| 5 | Create balanced alternative thought |
| 6 | Re-rate emotional distress |
Example transformation: Original: “If I don’t sleep 8 hours, I’ll lose my job” → Balanced: I may not feel great, but I can probably function at work.
4. Scheduled Worry Time
Protocol:
- Schedule 1 hour daily for worry
- When worry arises outside that time, write it down
- Redirect: “I’ll address this at 4:00 PM”
- During scheduled time, actually worry
- Clears “worry queue” before bedtime
Dual benefit: Unclutters daytime AND prevents nighttime worry intrusion.
5. Progressive Muscle Relaxation
Technique: Systematically squeeze and release muscle groups throughout the body (hands, arms, face, continuing through body). This is the one exception to “nothing in bed except sleep and sex.”
Sleep Hygiene Essentials
Temperature Regulation
| Factor | Recommendation |
| Room temperature | 65–68°F (18–20°C) ideal4 |
| Bedding | Cotton blankets ONLY; no down comforters or duvets |
| Hands/feet | Keep warm (helps dump core heat) |
| Pre-bed | Warm foot bath can help |
Temperature Mechanism
Body temperature must be coolest at night, warmest during day. Heat is a significant disruptor of REM sleep—when room temperature rises, body temperature follows, undoing the sleep initiation process.4 Trapping heat with down comforters disrupts circadian temperature rhythm. Note for older adults: Research suggests adults 65+ may sleep best at slightly warmer temperatures (68–77°F/20–25°C) due to reduced thermoregulation capacity.4
Light Exposure
| Factor | Recommendation |
| Room darkness | As dark as possible |
| Eye mask | Highly recommended, especially for early morning awakening |
| Electronic lights | Cover with electrical tape |
| Blue light | May matter less than stimulus from content |
Caffeine
| Recommendation | Rationale |
| Cut-off: 11:00 AM or 6+ hours before bed | Mean half-life ~5 hours (range: 1.5–9.5 hours)5 |
| Stop decaf after dinner | Contains up to 15–30% caffeine of regular |
| Keep amount constant | Don’t reduce total; just shift timing |
Genetic Variation
CYP1A2 polymorphisms divide the population into “fast” and “slow” caffeine metabolizers. Approximately 50–60% are fast metabolizers; 40–50% are slow metabolizers who may feel caffeine effects for up to 9 hours.5 University of Florida research found caffeine content in specialty coffee varies dramatically—from 259 mg to 564 mg in the same store on different days.6
Food, Alcohol & Exercise
| Factor | Recommendation |
| Food | No eating within 3 hours of bed |
| Alcohol | Eliminate during CBT-I treatment |
| Marijuana | Eliminate during treatment |
| Hydration | Time water intake earlier; electrolytes help reduce nighttime urination |
| Evening exercise | May be problematic for some; depends on heart rate recovery time |
| HIIT | Move earlier in day if possible |
| Yoga/stretching | Generally fine anytime |
Treatment Protocol
Typical Structure
| Week | Focus |
| Intake | Assessment, sleep diary, stabilize medications |
| Week 1 | Set consistent wake time; eliminate naps |
| Week 2 | Begin time in bed restriction |
| Week 3 | Add cognitive techniques |
| Week 4–5 | Refine, expand sleep window |
| Follow-up | Address remaining issues |
Setting Wake Time
| Step | Action |
| 1 | Review sleep diary for actual wake patterns |
| 2 | Choose wake time supported by evidence in diary |
| 3 | Don’t allow fantasy wake times (e.g., 8:30 if always waking at 6) |
| 4 | Maintain same wake time every day ending in “-day” |
Critical Point
Cannot control when you fall asleep; CAN control when you wake up. Wake time is the anchor.
Handling Naps
| Patient Type | Recommendation |
| Insomnia patient | Eliminate naps completely |
| Elderly (80+) | 25-minute nap with alarm acceptable |
| Sick/recovering | Naps okay; maintain stimulus control (nap in bed only) |
| Non-insomnia patient | Naps not problematic |
Middle-of-Night Awakening Protocol
- Get out of bed
- Do “mildly boring but entertaining” activity
- Check in with body: “Am I ready to sleep?”
- Return to bed only when sleepy
Appropriate activities: Solitaire, adult coloring books, reading pleasure (not stressful) material, 20-minute sitcom episode.
Avoid: Email, work, social media, stimulating content.
Medication Considerations
Medication Taper Protocol
| Phase | Action |
| Stabilization | Get to consistent dose/timing before reducing |
| Assessment | Rate anxiety about reduction (1–10 scale) |
| Reduction | Only reduce when anxiety is 1–2 |
| Increment | May be as small as 0.5 mg |
| Duration | 3 weeks minimum at each level |
| Pause | Stop taper during major life stressors |
Key Insight
Psychological dependency must be addressed alongside physiological. Tiny increments build confidence.
Medications to Stabilize Before CBT-I
| Medication | Approach |
| Ambien | Stabilize dose; no middle-of-night dosing |
| Benzos | Stabilize; taper AFTER CBT-I |
| Trazodone | Less concerning; may help depression |
| Benadryl/OTC | Stabilize, then eliminate |
Melatonin Considerations
| Finding | Implication |
| Studies found inaccurate labeling | Content ranged from 83% less to 478% more than labeled7 |
| Lot-to-lot variability | Can vary by up to 465% within same product7 |
| Serotonin contamination | Over 25% of products contained serotonin7 |
| Melatonin signals sleep onset only | Won’t keep you asleep |
| Maximum dose | ≤1 mg (300–600 mcg preferred) |
Beta-Blocker Exception
Beta-blocker patients may benefit from 0.5–2.5 mg melatonin supplementation—beta-blockers inhibit melatonin secretion via beta-1 receptor blockade, reducing nocturnal melatonin by 80–86%.8 Studies show 3 weeks of supplementation significantly improved total sleep time (+36 min) and sleep efficiency (+7.6%) in hypertensive patients on beta-blockers.8
Sleep Trackers
Recommendation: Remove sleep trackers during treatment.
| Rationale | Explanation |
| Creates anxiety | Constant monitoring increases sleep focus |
| Inaccurate | Can’t reliably detect sleep vs. quiet wakefulness |
| Creates obsession | Some patients distressed by tracker despite feeling fine |
Cognitive Techniques for Nighttime Anxiety
Tracking Degree of Belief
| Step | Action |
| 1 | Identify recurring worry thought |
| 2 | Rate belief in thought every few hours during day |
| 3 | Notice variation (high at 1 AM, low at 3 PM) |
| 4 | Recognize: “I believe this because it’s 1 AM, not because it’s true” |
Example: MS patient worried “I’ll never make it through this day” at 7 AM. By tracking belief levels throughout day, discovered she only believed this at 7 AM, never at 5 PM. This insight alone recaptured her mornings.
A-B Testing Sleep Interventions
| Protocol | Requirement |
| Duration | 2 weeks minimum |
| Tracking | Paper sleep diary |
| Variable | Change only ONE thing at a time |
| Assessment | Compare before and after |
Special Populations
Weekend Sleep (“Social Jet Lag”)
| Rule | Application |
| Never sleep in 2 days in a row | Choose which day to suffer |
| Maximum sleep-in | 1 hour |
| Strategy | Plan which day to prioritize feeling good |
Process S and Process C (Two-Process Model)
The two-process model of sleep regulation, proposed by Alexander Borbély in 1982, remains a foundational framework in sleep science.9
| Process | Function |
| Process S (Sleep Homeostasis) | Sleep pressure builds with wakefulness; drains during sleep |
| Process C (Circadian) | Controlled by circadian pacemaker; marches on regardless of sleep debt |
Why Naps Are Dangerous
Naps deflate the sleep pressure balloon, reducing drive for nighttime sleep. Caffeine blocks adenosine receptors, preventing detection of accumulated sleep pressure.
Finding Treatment
Resources
| Resource | Details |
| Society of Behavioral Sleep Medicine | Directory of CBT-I providers |
| Telemedicine | Greatly expanded access |
| Recommended book | Quiet Your Mind and Get to Sleep by Carney & Manber |
| Assessment tools | Pittsburgh Sleep Quality Index; Insomnia Severity Index |
What to Ask a CBT-I Provider
| Question | What to Look For |
| Can we schedule weekly sessions? | Yes; every 2 weeks insufficient |
| How many sessions? | 5–8 typical |
| Do you use sleep diaries? | Should calculate efficiency weekly |
| What components do you include? | Stimulus control + time restriction essential |
Self-Help Option
- Get the book (Quiet Your Mind and Get to Sleep)
- Complete included sleep diary
- Calculate sleep efficiency
- Follow protocol systematically
- Consider professional help if stuck
Key Studies & Data
| Finding | Result | Significance |
| CBT-I remission rate (meta-analysis)1 | 45–51% post-treatment to follow-up | Among best psychological treatment outcomes; effects stable 24+ months |
| Sleep efficiency target | 85% threshold | When achieved, sleep window expands 15 min/week |
| Caffeine half-life5 | Mean 5 hours (range 1.5–9.5) | Even morning coffee may persist; genetic variation affects metabolism |
| Two-process model9 | Process S + Process C interaction | Foundational sleep regulation framework since 1982 |
| Beta-blockers reduce melatonin8 | 80–86% reduction in nocturnal secretion | Supplementation improves sleep +36 min in affected patients |
| Melatonin labeling accuracy7 | 71% products fail 10% margin | Content varies 83% less to 478% more than labeled |
| Bedroom temperature4 | 65–68°F (18–20°C) optimal | Heat disrupts REM sleep; older adults may prefer warmer |
| Insomnia prevalence (DSM-5)3 | 8–12% point prevalence | Lower than older estimates using DSM-IV criteria |
Practical Guidance Summary
First Steps Before Seeking Treatment
| Priority | Action |
| 1 | Set consistent wake time (same every day) |
| 2 | Eliminate naps |
| 3 | Remove down comforters; use cotton blankets |
| 4 | Cut caffeine by 11 AM |
| 5 | No eating within 3 hours of bed |
| 6 | Keep room dark and cool (mid-60s) |
| 7 | Remove sleep tracker |
Warning Signs to Address First
| Issue | Action |
| Snoring/gasping | Get sleep apnea evaluation |
| Restless legs | Address with physician |
| CPAP non-compliance | Work to optimize fit/use |
| Major psychiatric disorder | May need concurrent treatment |
Additional Considerations
Study Limitations
- Most CBT-I meta-analyses rely on self-reported sleep diaries rather than polysomnography, potentially introducing measurement bias
- Many studies have relatively short follow-up periods (3–6 months), though some demonstrate durability at 24 months1
- Clinical trial participants may not fully represent real-world populations, including those with severe comorbidities
- Digital CBT-I programs show promise but have higher dropout rates than in-person therapy
Conflicting Evidence
- Optimal sleep temperature recommendations vary by age group—standard 65°F guidance may not apply to older adults who show better sleep at 68–77°F4
- Some studies suggest brief naps (<20 minutes) may be compatible with good sleep hygiene, contradicting strict nap prohibition
- The importance of sleep duration versus sleep quality remains debated; some research prioritizes efficiency over total time
Individual Variation
- CYP1A2 genetic polymorphisms create significant variation in caffeine metabolism—half-lives range from 1.5 to 9.5 hours5
- Response to CBT-I varies substantially, with approximately 30% classified as non-responders
- Circadian chronotypes (morning larks vs. night owls) affect optimal sleep timing independent of learned behaviors
- Comorbid conditions (depression, chronic pain, sleep apnea) may require modified CBT-I protocols
Safety Notes
- Time-in-bed restriction should not reduce sleep opportunity below 5.5 hours to avoid excessive daytime impairment
- Patients with bipolar disorder require careful monitoring during sleep restriction due to mania risk
- Melatonin supplements show significant quality control issues—over 71% fail accuracy standards, and some contain serotonin7
- Beta-blocker users experiencing insomnia should discuss melatonin supplementation with their physician before self-treating8
Evidence Gaps
- Limited research on CBT-I effectiveness in diverse racial and ethnic populations
- Optimal integration of digital and in-person CBT-I components remains understudied
- Long-term outcomes beyond 24 months lack robust data
- Mechanisms by which CBT-I produces neurobiological changes require further investigation
Recent Developments
- Digital CBT-I platforms have expanded access, with 2025 meta-analyses showing significant effectiveness for automated programs
- Network meta-analyses suggest CBT-I alone may be as effective as CBT-I plus pharmacotherapy, questioning combination approaches
- Research on CBT-I for comorbid depression shows dual benefits (OR 3.57 for insomnia remission)
- Growing interest in precision medicine approaches that match treatment intensity to patient phenotype
References
- Hertenstein E, et al. Cognitive behavioral therapy for adult insomnia disorder in routine clinical care: a systematic review and meta-analysis. Cognitive Behaviour Therapy. 2025. DOI: 10.1080/16506073.2025.2588173
- Trauer JM, et al. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Annals of Internal Medicine. 2015;163(3):191–204. DOI: 10.7326/M14-2841
- Straten A, et al. The prevalence of insomnia disorder in the general population: a meta-analysis. Journal of Sleep Research. 2025;34(1):e70089. DOI: 10.1111/jsr.70089
- Lan L, et al. Nighttime ambient temperature and sleep in community-dwelling older adults. Science of the Total Environment. 2023;899:165650. DOI: 10.1016/j.scitotenv.2023.165650
- Institute of Medicine. Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. National Academies Press. 2001. Pharmacology of Caffeine chapter.
- McCusker RR, et al. Caffeine content of specialty coffees. Journal of Analytical Toxicology. 2003;27(7):520–522. DOI: 10.1093/jat/27.7.520
- Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine. 2017;13(2):275–281. DOI: 10.5664/jcsm.6462
- Scheer FA, et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–1402. DOI: 10.5665/sleep.2122
- Borbély AA, et al. The two-process model of sleep regulation: beginnings and outlook. Journal of Sleep Research. 2022;31(4):e13598. DOI: 10.1111/jsr.13598
Medical Disclaimer: This educational brief is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any new health regimen. Individual results may vary. The information presented reflects current research as of January 2026 and may be updated as new evidence becomes available.